MIRA Pharmaceuticals
MIRA
19 hedge funds and large institutions have $949K invested in MIRA Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 8 closing their positions.
0.93% less ownership
Funds ownership: 6.78% → 5.85% (-0.93%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
21% less funds holding
Funds holding: 24 → 19 (-5)
26% less capital invested
Capital invested by funds: $1.28M → $949K (-$330K)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SEM
Suncoast Equity Management
Tampa,
Florida
|
+$91.9K |
| 2 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$45.6K |
| 3 |
Jane Street
New York
|
+$16.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.2K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$112K |
| 2 |
VF
Virtu Financial
New York
|
-$72K |
| 3 |
Renaissance Technologies
New York
|
-$52.2K |
| 4 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$31.9K |
| 5 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$28.8K |
MIRA Hedge Fund Activity: Q1 2025 in Review
19 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q1 2025, worth a combined $949K — down 26% from $1.28M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MIRA and 3 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Suncoast Equity Management, adding an estimated $91.9K. The largest seller was Citadel Advisors, exiting entirely with an estimated $112K sold.
- 19 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q1 2025, down from 24 in Q4 2024.
- Funds reported $949K of MIRA Pharmaceuticals stock for Q1 2025, down 26% quarter-over-quarter.
- 3 funds opened new MIRA Pharmaceuticals positions in Q1 2025 and 8 closed out, a net change of -5 holders.
- The largest MIRA Pharmaceuticals buyer in Q1 2025 was Suncoast Equity Management, an estimated $91.9K added.
- The largest MIRA Pharmaceuticals seller in Q1 2025 was Citadel Advisors, an estimated $112K sold.
Based on aggregated 13F filings for Q1 2025.